543 related articles for article (PubMed ID: 10321635)
1. Primary cutaneous Ki-1(CD30) positive anaplastic large cell lymphoma in childhood.
Tomaszewski MM; Moad JC; Lupton GP
J Am Acad Dermatol; 1999 May; 40(5 Pt 2):857-61. PubMed ID: 10321635
[TBL] [Abstract][Full Text] [Related]
2. Should primary cutaneous Ki-1(CD30)-positive anaplastic large cell lymphoma in childhood be treated with multiple-agent chemotherapy?
Vermeer MH; Bekkenk MW; Willemze R
J Am Acad Dermatol; 2001 Oct; 45(4):638-40. PubMed ID: 11568767
[No Abstract] [Full Text] [Related]
3. Cutaneous CD30 (Ki-1)-positive anaplastic large cell lymphoma preceded by Hodgkin's disease.
Terao H; Kiryu H; Ohshima K; Kikuchi M; Furue M
J Dermatol; 2000 Mar; 27(3):170-3. PubMed ID: 10774143
[TBL] [Abstract][Full Text] [Related]
4. [Primary cutaneous CD30-positive anaplastic large cell lymphoma].
Shi Q; Xu X; Yin H; Zhou X; Zhang T; Sun G; Mikihiro S; Qian B
Zhonghua Bing Li Xue Za Zhi; 2001 Apr; 30(2):97-100. PubMed ID: 11866962
[TBL] [Abstract][Full Text] [Related]
5. Primary gastric CD30 (Ki-1)-positive large cell non-Hodgkin's lymphomas. A clinicopathologic analysis of six cases.
Paulli M; Rosso R; Kindl S; Boveri E; Bonoldi E; Stracca V; Motta T; Arrigoni G; Lazzarino M; Menestrina F
Cancer; 1994 Feb; 73(3):541-9. PubMed ID: 8299075
[TBL] [Abstract][Full Text] [Related]
6. Primary cutaneous CD30-positive anaplastic large cell lymphoma in childhood: report of 4 cases and review of the literature.
Kumar S; Pittaluga S; Raffeld M; Guerrera M; Seibel NL; Jaffe ES
Pediatr Dev Pathol; 2005; 8(1):52-60. PubMed ID: 15719203
[TBL] [Abstract][Full Text] [Related]
7. A comparison of clinical, morphological and immunohistochemical features of lymphomatoid papulosis and primary cutaneous CD30(Ki-1)-positive anaplastic large cell lymphoma.
Tomaszewski MM; Lupton GP; Krishnan J; May DL
J Cutan Pathol; 1995 Aug; 22(4):310-8. PubMed ID: 7499570
[TBL] [Abstract][Full Text] [Related]
8. The t(2;5) chromosomal translocation is not a common feature of primary cutaneous CD30+ lymphoproliferative disorders: comparison with anaplastic large-cell lymphoma of nodal origin.
DeCoteau JF; Butmarc JR; Kinney MC; Kadin ME
Blood; 1996 Apr; 87(8):3437-41. PubMed ID: 8605362
[TBL] [Abstract][Full Text] [Related]
9. Primary Cutaneous Small Cell Variant of Anaplastic Large Cell Lymphoma: A Case Series and Review of the Literature.
Magro CM; Momtahen S; Kiuru M
Am J Dermatopathol; 2017 Dec; 39(12):877-889. PubMed ID: 28570392
[TBL] [Abstract][Full Text] [Related]
10. Primary cutaneous Ki-1+ anaplastic large cell lymphoma: a morphologic, immunohistochemical and genetic study of an indolent case.
Sato N; Sato K; Yagi E; Tomita Y
J Dermatol; 1995 Jun; 22(6):441-9. PubMed ID: 7650245
[TBL] [Abstract][Full Text] [Related]
11. Childhood anaplastic large cell lymphoma Ki-1/CD30: clinicopathologic features of 19 cases.
Rubie H; Gladieff L; Robert A; Gaubert I; Huguet F; Rochaix P; Pein F; Michel G; Hoerni B; Sommelet D
Med Pediatr Oncol; 1994; 22(3):155-61. PubMed ID: 8272005
[TBL] [Abstract][Full Text] [Related]
12. Ki-1(CD30) positive anaplastic large cell lymphoma: primary nodal disease relapsing as erythroderma.
Goyal S; Brinster NK; Goyal S
J Am Acad Dermatol; 2002 Aug; 47(2 Suppl):S201-4. PubMed ID: 12140462
[TBL] [Abstract][Full Text] [Related]
13. CD56 expression in a case of primary cutaneous CD30+ anaplastic large cell lymphoma.
Chang SE; Park IJ; Huh J; Choi JH; Sung KJ; Moon KC; Koh JK
Br J Dermatol; 2000 Apr; 142(4):766-70. PubMed ID: 10792229
[TBL] [Abstract][Full Text] [Related]
14. CD30 antigen in non-Hodgkin's lymphoma.
Miyake K; Yoshino T; Sarker AB; Teramoto N; Akagi T
Pathol Int; 1994 Jun; 44(6):428-34. PubMed ID: 8055109
[TBL] [Abstract][Full Text] [Related]
15. Variable loss of CD30 expression by immunohistochemistry in recurrent cutaneous CD30+ lymphoid neoplasms treated with brentuximab vedotin.
Goyal A; Patel S; Goyal K; Morgan EA; Foreman RK
J Cutan Pathol; 2019 Nov; 46(11):823-829. PubMed ID: 31286556
[TBL] [Abstract][Full Text] [Related]
16. [A clinico-pathological and immunohistochemical study on anaplastic large cell lymphoma].
Jin X; Li C; Ding C; Chu Q
Zhonghua Bing Li Xue Za Zhi; 1999 Jun; 28(3):194-6. PubMed ID: 11869528
[TBL] [Abstract][Full Text] [Related]
17. Primary cutaneous CD30 (Ki-1)-positive non-anaplastic B-cell lymphoma.
Herrera E; Gallardo M; Bosch R; Cabra B; Aneri V; Sánchez P
J Cutan Pathol; 2002 Mar; 29(3):181-4. PubMed ID: 11972717
[TBL] [Abstract][Full Text] [Related]
18. CD30/Ki-1-positive lymphoproliferative disorders of the skin--clinicopathologic correlation and statistical analysis of 86 cases: a multicentric study from the European Organization for Research and Treatment of Cancer Cutaneous Lymphoma Project Group.
Paulli M; Berti E; Rosso R; Boveri E; Kindl S; Klersy C; Lazzarino M; Borroni G; Menestrina F; Santucci M
J Clin Oncol; 1995 Jun; 13(6):1343-54. PubMed ID: 7751878
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical analysis of CD30-positive lymphoproliferative disorders for expression of CD95 and CD95L.
Sigel JE; Hsi ED
Mod Pathol; 2000 Apr; 13(4):446-51. PubMed ID: 10786813
[TBL] [Abstract][Full Text] [Related]
20. Is immunohistochemical expression of GATA3 helpful in the differential diagnosis of transformed mycosis fungoides and primary cutaneous CD30-positive T cell lymphoproliferative disorders?
Collins K; Gu J; Aung PP; Nagarajan P; Curry JL; Huen A; Ivan D; Prieto VG; Tetzlaff MT; Duvic M; Miranda RN; Vega F; Torres-Cabala CA
Virchows Arch; 2021 Aug; 479(2):377-383. PubMed ID: 33604757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
